Safety and Efficacy Study of ONGLYZA (Saxagliptin) Under Conditions of Actual Use

A Descriptive Study of the Efficacy and Safety of ONGLYZA (Saxagliptin) Under Conditions of Actual Use in the Philippines

This post marketing surveillance study aims to monitor the safety and efficacy of ONGLYZA under conditions of actual use in patients who are diagnosed with diabetes mellitus type 2 and are prescribed ONGLYZA by their physician.

Inclusion Criteria:

• Diagnosis of Type 2 Diabetes Mellitus
• Prescribed Saxagliptin by patient's attending physician

Exclusion Criteria:

• Known allergic or serious adverse reaction to Saxagliptin
• Pregnant or breastfeeding patients